Francesco Menichetti - Infectious Diseases

Author Information

Francesco Menichetti is a prominent researcher in the field of Infectious Diseases. He is affiliated with the Infectious Diseases Department at Cisanello Hospital, which is part of the Azienda Ospedaliera Universitaria Pisana in Pisa, Italy. His work is critical in advancing the understanding and treatment of infectious diseases, and he is associated with numerous scholarly contributions in this domain.

Research Contributions

Francesco Menichetti has made significant contributions to infectious disease research, with a particular focus on viral pneumonia, COVID-19, and related complications. His recent works include studies on the ictogenesis of viral pneumonia comparing SARS-CoV-2 and H1N1/H3N2, the use of Remdesivir in COVID-19 patients, and the evaluation of treatment regimens for severe infections caused by carbapenem-resistant Acinetobacter baumannii. His research extends to areas such as the early diagnosis of COVID-19 pneumonia using lung ultrasound, the role of chemokines in COVID-19-associated pneumonia, and risk stratification in patients with COVID-19. His work is characterized by its clinical relevance and interdisciplinary approach, addressing both the diagnosis and treatment of complex infectious conditions.

Aliases

Francesco Menichetti is also known in the academic community by several aliases, including F Menichetti and F. Menichetti. These variations are often used in publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	8,854
h-index	50
Total Paper Count	306

Publications:

Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2

DOI: 10.1016/j.yebeh.2021.108470

Year: 2022

The WSES/SICG/ACOI/SICUT/AcEMC/SIFIPAC guidelines for diagnosis and treatment of acute left colonic diverticulitis in the elderly

DOI: 10.1186/s13017-022-00408-0

Year: 2022

Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19

DOI: 10.1016/j.clinthera.2022.01.007

Year: 2022

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

DOI: 10.1128/aac.02142-21

Year: 2022

Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study

DOI: 10.1186/s13054-021-03840-x

Year: 2021

Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study

DOI: 10.1007/s00134-021-06373-7

Year: 2021

Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19

DOI: 10.1038/s41598-021-99050-0

Year: 2021

C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study

DOI: 10.1016/j.thromres.2021.06.003

Year: 2021

Diabetes and acute bacterial skin and skin structure infections.

DOI: 10.1016/j.diabres.2021.108732

Year: 2021

Exercise-induced pulmonary hypertension in HIV patients: Association with poorer clinical and immunological status.

DOI: 10.1016/j.vph.2021.106888

Year: 2021

What Treatments are Available for Dengue?

What is respiratory hygiene and why is it important?

What is the Future of Genomic Sequencing in Infectious Diseases?

What is the Importance of International Collaboration?

How Long Can Respiratory Droplets Remain Infectious?

What Should You Do if You Suspect Contamination?

How is Avian Influenza Diagnosed?

How is Botulism Transmitted?

Can Vaccinations Help Prevent Infectious Diseases in Pregnancy?

What is Zika Virus?

Partnered Content Networks

Relevant Topics